(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TRX

ST13

US500000085594863

Class

5, 10, 40, 42

Filing

85594863

Registration

4975748

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

81

Latest update

08/04/2026

Trademark type

Word

Nice classes

5, 10, 40, 42

Filing date

04/11/2012

Registration date

06/14/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/04/2026

Last transaction

08/04/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Garforth, GB

Examiner

VANSTON, KATHY

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Tissue Regenix Limited
Tissue Regenix Limited

Representatives

Robert L. McRae GUNN, LEE & CAVE, P.C

Technical classification

Nice Classes

Class 5Class 10Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Living tissues for surgical implant; guided tissue regeneration materials comprised of biological decellularised material; implants comprising biological decellularised tissue for guided tissue regeneration; arteriovenous graftssurgical patches for vascular reconstructionreplacement heart valvessmall diameter graftsreplacement cartilage tissuesall made of living tissue; materials for dressingsgauze swabsbandagesself-adhesive bandages; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals ; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria

Class 10

Implantable textile material to encourage the growth of tissue; replacement tissueartificial tissue being non-living surgical implants originally derived from humans and animalsintended for subsequent implantation comprising boneskinskin graftsuretersbladderstendonscartilageligamentsblood vesselsnervesdermal replacementstissue for use in treating chronic and acute woundstissue for use in treating burnssoft tissue used in the heart and pericardium; replacement prosthetic tissue for replacing animal tissue; replacement prosthetic tissue for replacing human tissue; implantable medical scaffolds comprising artificial materials for assisting regeneration of living tissue for living tissue; prosthetic arteriovenous graftsprosthetic replacement heart valvesprosthetic small diameter grafts; suture materials; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals ; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria

Class 40

Treatment of living cells and tissueremoving immunogenic materials; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria

Class 42

Research and design services in the field of replacement tissues for humans and animalsregenerative medical devices; laboratory servicesresearch pertaining to material treatment for the production of living cellsproduction and decellularisation of tissuetreatment of replacement tissues for use in the human body and in animals; all of aforesaid in the field of replacement tissues for humans and animals and replacement body parts for humans and animals; and none relating to neurological diseases and disordersneurodegenerative diseases and disordersinfectious diseases and malaria

Publications

History of USPTO decisions and trademark events.

81 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/04/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/04/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/04/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/04/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/26/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/26/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/26/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

06/04/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/14/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/06/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/06/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/17/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/17/2023

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

05/17/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/17/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/17/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/17/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/27/2022

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/27/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/21/2022

E815

TEAS SECTION 8 & 15 RECEIVED

06/08/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/14/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/12/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

06/14/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/29/2016

PUBO

PUBLISHED FOR OPPOSITION

03/29/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/09/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/19/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/12/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/28/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/28/2016

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/20/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/21/2015

GNSL

LETTER OF SUSPENSION E-MAILED

09/21/2015

CNSL

SUSPENSION LETTER WRITTEN

09/21/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/19/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/19/2015

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/14/2015

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

04/16/2015

GNSI

INQUIRY TO SUSPENSION E-MAILED

04/16/2015

CNSI

SUSPENSION INQUIRY WRITTEN

04/16/2015

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

04/15/2015

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/15/2014

GNSL

LETTER OF SUSPENSION E-MAILED

10/15/2014

CNSL

SUSPENSION LETTER WRITTEN

10/15/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/15/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/15/2014

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/08/2014

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

09/29/2014

GNSI

INQUIRY TO SUSPENSION E-MAILED

09/29/2014

CNSI

SUSPENSION INQUIRY WRITTEN

09/29/2014

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/27/2014

GNSL

LETTER OF SUSPENSION E-MAILED

03/27/2014

CNSL

SUSPENSION LETTER WRITTEN

03/27/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/26/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/26/2014

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/26/2014

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/29/2014

GNSL

LETTER OF SUSPENSION E-MAILED

01/29/2014

CNSL

SUSPENSION LETTER WRITTEN

01/29/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/29/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/29/2014

ALIE

ASSIGNED TO LIE

01/26/2014

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/16/2014

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

08/13/2013

GNSI

INQUIRY TO SUSPENSION E-MAILED

08/13/2013

CNSI

SUSPENSION INQUIRY WRITTEN

08/13/2013

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/13/2013

GNSL

LETTER OF SUSPENSION E-MAILED

02/13/2013

CNSL

SUSPENSION LETTER WRITTEN

02/13/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/23/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/22/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/22/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/27/2012

GNRT

NON-FINAL ACTION E-MAILED

07/27/2012

CNRT

NON-FINAL ACTION WRITTEN

07/27/2012

DOCK

ASSIGNED TO EXAMINER

07/25/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/18/2012

NWAP

NEW APPLICATION ENTERED

04/14/2012

Continuous trademark protection

Get notified about every new filing that threatens TRX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.